chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Pain in extremity, Pruritus
Clinical narrative: Her right foot is still hard, it goes numb; Her right foot is still hard, it goes numb; Feels like it weights a hundred pounds; foot still hurts; Couldn't move the right Hip and below; Itchiness; Red patches; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPERKERATOSIS (Her right foot is still hard, it goes numb), HYPOAESTHESIA (Her right foot is still hard, it goes numb), LIMB DISCOMFORT (Feels like it weights a hundred pounds), PAIN IN EXTREMITY (Arm pain) and PRURITUS (Itchiness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroiditis. Concomitant products included AMLODIPINE, ATORVASTATIN, VITAMINS NOS, OXYBUTYNIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and OMEPRAZOLE for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 16-Feb-2021, the patient experienced PRURITUS (Itchiness) and ERYTHEMA (Red patches). On 18-Feb-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (Couldn't move the right Hip and below). In March 2021, the patient experienced HYPERKERATOSIS (Her right foot is still hard, it goes numb), HYPOAESTHESIA (Her right foot is still hard, it goes numb), LIMB DISCOMFORT (Feels like it weights a hundred pounds) and PAIN IN EXTREMITY (foot still hurts). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. At the time of the report, HYPERKERATOSIS (Her right foot is still hard, it goes numb), HYPOAESTHESIA (Her right foot is still hard, it goes numb) and LIMB DISCOMFORT (Feels like it weights a hundred pounds) outcome was unknown, PAIN IN EXTREMITY (Arm pain), PRURITUS (Itchiness), ERYTHEMA (Red patches) and MUSCULOSKELETAL DISCOMFORT (Couldn't move the right Hip and below) was resolving and PAIN IN EXTREMITY (foot still hurts) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Computerised tomogram: (normal) Normal. In March 2021, Computerised tomogram: (normal) CT scan was clear..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included an unspecified thyroid medication. Treatment for the events included topical cream and unknown pills.   Most recent FOLLOW-UP information incorporated above includes: On 04-Mar-2021: New event right foot is still hard, it goes numb and feels like it weights a hundred pounds were reported. New lab test CT scan was reported. On 09-Jul-2021: Event added.
Sex: F
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: Loss of taste; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (Loss of taste). At the time of the report, AGEUSIA (Loss of taste) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pyrexia
Clinical narrative: chills; slight nausea; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), NAUSEA (slight nausea) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No relevant concomitant medications reported No relevant medical history was reported.     On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PYREXIA (fever), NAUSEA (slight nausea) and HEADACHE (headache). On an unknown date, the patient experienced CHILLS (chills). On 27-Feb-2021, PYREXIA (fever) had resolved. At the time of the report, CHILLS (chills) had resolved and NAUSEA (slight nausea) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Received her first vaccine and then contracted with Covid 19; A spontaneous report was received from a consumer concerning a female patient of an unknown age who received first dose of Moderna's COVID-19 vaccine (mRNA-1273) and contracted with COVID-19.      The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, after receiving first vaccine and the patient contracted with COVID-19. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event contracted with COVID-19 was not reported.; Sender's Comments: COVID-19 in this patient is unlikely to be due to the Moderna COVID-19 vaccine
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Headache, Pain in extremity, Pyrexia
Clinical narrative: arm soreness; back aches; chills; headache; fever 101.3; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), BACK PAIN (back aches), CHILLS (chills) and PYREXIA (fever 101.3) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No relevant medical history was reported.  Concomitant products included ALBUTEROL [SALBUTAMOL], VITAMIN B12 [VITAMIN B12 NOS] and VITAMIN D3 for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), BACK PAIN (back aches), CHILLS (chills) and PYREXIA (fever 101.3). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. On 19-Feb-2021, PAIN IN EXTREMITY (arm soreness) and BACK PAIN (back aches) had resolved. At the time of the report, CHILLS (chills) and PYREXIA (fever 101.3) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Low grade fever; Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever), CHILLS (Chills) and PAIN (Body aches) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus, Neuropathy, Cholesterol and Sleep disorder. Concomitant products included ATORVASTATIN for Cholesterol, INSULIN DETEMIR (LEVEMIR) and SITAGLIPTIN (JANUVIA [SITAGLIPTIN]) for Diabetes mellitus, GABAPENTIN for Neuropathy, ALPRAZOLAM (XANAX) for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced PYREXIA (Low grade fever), CHILLS (Chills) and PAIN (Body aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Low grade fever), CHILLS (Chills) and PAIN (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Asthenia, Dizziness
Clinical narrative: experiencing her aging signs increasing; feeling dizzier; feeling weaker; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (experiencing her aging signs increasing), DIZZINESS (feeling dizzier) and ASTHENIA (feeling weaker) in a 97-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced ADVERSE EVENT (experiencing her aging signs increasing), DIZZINESS (feeling dizzier) and ASTHENIA (feeling weaker). At the time of the report, ADVERSE EVENT (experiencing her aging signs increasing), DIZZINESS (feeling dizzier) and ASTHENIA (feeling weaker) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Rash
Clinical narrative: Rash in chest / rash at the back / rash in both arms; Redness; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash in chest / rash at the back / rash in both arms) and ERYTHEMA (Redness) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol, Hypertension and Anxiety. Concomitant products included MIRTAZAPINE for Anxiety, SIMVASTATIN for Cholesterol, AMLODIPINE for Hypertension, GABAPENTIN for an unknown indication.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced RASH (Rash in chest / rash at the back / rash in both arms) and ERYTHEMA (Redness). At the time of the report, RASH (Rash in chest / rash at the back / rash in both arms) and ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Influenza like illness, Nausea, Vomiting
Clinical narrative: I felt like I got sicker the more I laid down; feel like I have the flu; I threw up all the water I had; can't eat anything because of the nausea; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I felt like I got sicker the more I laid down), INFLUENZA LIKE ILLNESS (feel like I have the flu), VOMITING (I threw up all the water I had) and NAUSEA (can't eat anything because of the nausea) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (being positive) in December 2020. Concomitant products included PIOGLITAZONE HYDROCHLORIDE (ACTOS), FUROSEMIDE, LEVOTHYROXINE, LOSARTAN, CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]), OMEPRAZOLE, ACETYLSALICYLIC ACID (BABY ASPIRIN), SERTRALINE, TICAGRELOR (BRILINTA), VITAMIN D3 and REPAGLINIDE (PRANDIN [REPAGLINIDE]) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ILLNESS (I felt like I got sicker the more I laid down), INFLUENZA LIKE ILLNESS (feel like I have the flu), VOMITING (I threw up all the water I had) and NAUSEA (can't eat anything because of the nausea). At the time of the report, ILLNESS (I felt like I got sicker the more I laid down), INFLUENZA LIKE ILLNESS (feel like I have the flu), VOMITING (I threw up all the water I had) and NAUSEA (can't eat anything because of the nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Thinking abnormal
Clinical narrative: I can't think; Serious headache; Fever / It went from 100 - 101, and the top it reached was 102.4; This spontaneous case was reported by a consumer and describes the occurrence of THINKING ABNORMAL (I can't think), PYREXIA (Fever / It went from 100 - 101, and the top it reached was 102.4) and HEADACHE (Serious headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Seizure and Arthritis.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (Fever / It went from 100 - 101, and the top it reached was 102.4). On an unknown date, the patient experienced THINKING ABNORMAL (I can't think) and HEADACHE (Serious headache). At the time of the report, THINKING ABNORMAL (I can't think), PYREXIA (Fever / It went from 100 - 101, and the top it reached was 102.4) and HEADACHE (Serious headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medicines include seizure and arthritis medicines .  Treatment Medications were not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Mammogram
Clinical narrative: Breasts were severely sore; Under the arm very sore; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (Breasts were severely sore) and AXILLARY PAIN (Under the arm very sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (Breasts were severely sore) and AXILLARY PAIN (Under the arm very sore). At the time of the report, BREAST PAIN (Breasts were severely sore) and AXILLARY PAIN (Under the arm very sore) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Mammogram: other (Inconclusive) Patient had a mammogram after the first shot..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema peripheral, Pain in extremity, Rash, Vaccination site reaction
Clinical narrative: edema on my legs; 6 inch long and 2 inch wide patch of pink rash/ rash on my back/rash on my legs; sore; 2 little circles around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore), VACCINATION SITE REACTION (2 little circles around the injection site), RASH (6 inch long and 2 inch wide patch of pink rash/ rash on my back/rash on my legs) and OEDEMA PERIPHERAL (edema on my legs) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore) and VACCINATION SITE REACTION (2 little circles around the injection site). On 22-Feb-2021, the patient experienced RASH (6 inch long and 2 inch wide patch of pink rash/ rash on my back/rash on my legs). On 02-Mar-2021, the patient experienced OEDEMA PERIPHERAL (edema on my legs). At the time of the report, PAIN IN EXTREMITY (sore), RASH (6 inch long and 2 inch wide patch of pink rash/ rash on my back/rash on my legs) and OEDEMA PERIPHERAL (edema on my legs) outcome was unknown and VACCINATION SITE REACTION (2 little circles around the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Pyrexia
Clinical narrative: Chills; Diarrhea; fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), DIARRHOEA (Diarrhea), PYREXIA (fever) and FATIGUE (Fatigue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced CHILLS (Chills), DIARRHOEA (Diarrhea), PYREXIA (fever) and FATIGUE (Fatigue). At the time of the report, CHILLS (Chills), DIARRHOEA (Diarrhea), PYREXIA (fever) and FATIGUE (Fatigue) outcome was unknown. Not Provided          Concomitant medications were not provided. Treatment details were not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, COVID-19, Cough, Feeling abnormal, Head discomfort
Clinical narrative: Tested positive for COVID-19; Feels like a cough in her head; Feels a bit bad; Loss of smell; Cough; Headache; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19), HEAD DISCOMFORT (Feels like a cough in her head), FEELING ABNORMAL (Feels a bit bad), ANOSMIA (Loss of smell) and COUGH (Cough) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HEAD DISCOMFORT (Feels like a cough in her head), FEELING ABNORMAL (Feels a bit bad), ANOSMIA (Loss of smell), COUGH (Cough) and HEADACHE (Headache). On 26-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19), HEAD DISCOMFORT (Feels like a cough in her head), FEELING ABNORMAL (Feels a bit bad), ANOSMIA (Loss of smell), COUGH (Cough) and HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medications were not reported.   The patient reported that her COVID symptoms were really mild and never needed oxygen or felt too bad. The patient stated that the only thing that bothered her was having no sense of smell for about a week. The patient felt completely well at the time of this report.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Outcome of the events were changed from Unknown to recovered.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, SARS-CoV-2 test
Clinical narrative: Tested positive for COVID-19; Feels like a cough in her head; Feels a bit bad; Loss of smell; Cough; Headache; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19), HEAD DISCOMFORT (Feels like a cough in her head), FEELING ABNORMAL (Feels a bit bad), ANOSMIA (Loss of smell) and COUGH (Cough) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HEAD DISCOMFORT (Feels like a cough in her head), FEELING ABNORMAL (Feels a bit bad), ANOSMIA (Loss of smell), COUGH (Cough) and HEADACHE (Headache). On 26-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19), HEAD DISCOMFORT (Feels like a cough in her head), FEELING ABNORMAL (Feels a bit bad), ANOSMIA (Loss of smell), COUGH (Cough) and HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medications were not reported.   The patient reported that her COVID symptoms were really mild and never needed oxygen or felt too bad. The patient stated that the only thing that bothered her was having no sense of smell for about a week. The patient felt completely well at the time of this report.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Outcome of the events were changed from Unknown to recovered.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain is going up the neck) and VACCINATION SITE PAIN (Her left arm started hurting like devil) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included Mastectomy (Had a Mastectomy 40years ago).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 03-Mar-2021, the patient experienced NECK PAIN (Pain is going up the neck) and VACCINATION SITE PAIN (Her left arm started hurting like devil). At the time of the report, NECK PAIN (Pain is going up the neck) and VACCINATION SITE PAIN (Her left arm started hurting like devil) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Pain in extremity
Clinical narrative: arm soreness; Local redness "2-3 inches below injection site and about 6 inches wide"; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) and INJECTION SITE ERYTHEMA (Local redness "2-3 inches below injection site and about 6 inches wide") in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm soreness) and INJECTION SITE ERYTHEMA (Local redness "2-3 inches below injection site and about 6 inches wide"). At the time of the report, PAIN IN EXTREMITY (arm soreness) and INJECTION SITE ERYTHEMA (Local redness "2-3 inches below injection site and about 6 inches wide") outcome was unknown.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Headache, Oxygen saturation
Clinical narrative: a very strong headache/a generalized headache, in all the head; This spontaneous case was reported by a health care professional and describes the occurrence of HEADACHE (a very strong headache/a generalized headache, in all the head) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024W20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Hypertension, Diabetes and Cholesterol.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced HEADACHE (a very strong headache/a generalized headache, in all the head). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (a very strong headache/a generalized headache, in all the head) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: (Inconclusive) normal. On an unknown date, Oxygen saturation: % (Inconclusive) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications for blood pressure, cholesterol, stomach, diabetes and for sleep. (Information not provided)
Sex: F
Vaccine: COVID19
Symptoms: Injection site irritation, Injection site pruritus, Injection site rash, Rash
Clinical narrative: annoying; little rash; itchy; (rash) is even in my scalp; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE IRRITATION (annoying), INJECTION SITE RASH (little rash), INJECTION SITE PRURITUS (itchy) and RASH ((rash) is even in my scalp) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE IRRITATION (annoying), INJECTION SITE RASH (little rash), INJECTION SITE PRURITUS (itchy) and RASH ((rash) is even in my scalp). At the time of the report, INJECTION SITE IRRITATION (annoying), INJECTION SITE RASH (little rash), INJECTION SITE PRURITUS (itchy) and RASH ((rash) is even in my scalp) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not provided. Treatment details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: Body Aches; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body Aches) and VACCINATION SITE PAIN (Soreness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced MYALGIA (Body Aches) and VACCINATION SITE PAIN (Soreness). At the time of the report, MYALGIA (Body Aches) and VACCINATION SITE PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Musculoskeletal stiffness
Clinical narrative: artificial joints in my neck feeling very stiff; feel tired; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (artificial joints in my neck feeling very stiff) and FATIGUE (feel tired) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included Joint arthroplasty (due to an accident years ago).   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (artificial joints in my neck feeling very stiff) and FATIGUE (feel tired). At the time of the report, MUSCULOSKELETAL STIFFNESS (artificial joints in my neck feeling very stiff) and FATIGUE (feel tired) was resolving.            No concomitant information was provided. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: event start date added, outcome updated from unknown to recovering
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain
Clinical narrative: Neck pain is getting worse; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain is getting worse) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 immunisation.     No medical history was provided by the reporter.     On 05-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced NECK PAIN (Neck pain is getting worse). At the time of the report, NECK PAIN (Neck pain is getting worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Product availability issue, Product dose omission issue
Clinical narrative: Original vaccine administration site no longer had Moderna available for patient's second dose; Missed dose; A spontaneous report was received from a consumer, concerning her husband, a male patient of unspecified age, who received Moderna's COVID-19 vaccine (mRNA-1273) and original vaccine administration site no longer had Moderna available for patient's second dose/ product availability issue and missed dose.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 26 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 26 Jan 2021, patient's original vaccine administration site no longer had Moderna available for patient's second dose and several other clinics had also refused the vaccine to patient as patient did not obtain his first dose at their facility. No treatment information was provided.  Action taken with mRNA-1273 in response to the events were not reported.   The outcome of events original vaccine administration site no longer had Moderna available for patient's second dose and missed dose were considered unknown at the time of this report.; Reporter's Comments: This report refers to a male patient of unspecified age who experienced non-serious unexpected event of original vaccine administration site no longer had Moderna available for patient's second dose/ (product availability issue and missed dose). There were no reported AEs associated with this case of product availability issue and missed dose.
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pain, Sinus disorder
Clinical narrative: Felt cold; Sinuses were messed up; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Felt cold), SINUS DISORDER (Sinuses were messed up) and PAIN (Body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced NASOPHARYNGITIS (Felt cold), SINUS DISORDER (Sinuses were messed up) and PAIN (Body aches). At the time of the report, NASOPHARYNGITIS (Felt cold), SINUS DISORDER (Sinuses were messed up) and PAIN (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Treatment medication was not provided by the reporter.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pruritus, Rash, Vaccination site pain
Clinical narrative: generalized rash that she got after she had the Moderna shot on day 8-9; Back was itching; fatigue; vaccination site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Back was itching), VACCINATION SITE PAIN (vaccination site tenderness), RASH (generalized rash that she got after she had the Moderna shot on day 8-9) and FATIGUE (fatigue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (allergic to doxycycline).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PAIN (vaccination site tenderness). On 19-Feb-2021, the patient experienced FATIGUE (fatigue). On 26-Feb-2021, the patient experienced PRURITUS (Back was itching). On an unknown date, the patient experienced RASH (generalized rash that she got after she had the Moderna shot on day 8-9). On 19-Feb-2021, FATIGUE (fatigue) had resolved. On 20-Feb-2021, VACCINATION SITE PAIN (vaccination site tenderness) had resolved. On 05-Mar-2021, PRURITUS (Back was itching) had resolved. At the time of the report, RASH (generalized rash that she got after she had the Moderna shot on day 8-9) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient had bath and body brand lotion and Zyrtec as treatment medication.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: NNI
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site reaction, Vaccination site warmth
Clinical narrative: Big circle at the site of injection; Warm to the touch circle at the site of injection; Red circle at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of ADMINISTRATION SITE INDENTATION (Big circle at the site of injection), VACCINATION SITE WARMTH (Warm to the touch circle at the site of injection) and VACCINATION SITE ERYTHEMA (Red circle at the site of injection) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced ADMINISTRATION SITE INDENTATION (Big circle at the site of injection), VACCINATION SITE WARMTH (Warm to the touch circle at the site of injection) and VACCINATION SITE ERYTHEMA (Red circle at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ADMINISTRATION SITE INDENTATION (Big circle at the site of injection), VACCINATION SITE WARMTH (Warm to the touch circle at the site of injection) and VACCINATION SITE ERYTHEMA (Red circle at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Pain in extremity
Clinical narrative: Sore arm; large blisters; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and BLISTER (large blisters) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and BLISTER (large blisters). At the time of the report, PAIN IN EXTREMITY (Sore arm) and BLISTER (large blisters) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  No treatment information provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swollen arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 002A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported adverse event).   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swollen arm). At the time of the report, VACCINATION SITE SWELLING (swollen arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Tearfulness
Clinical narrative: Lot of anxiety; Very teary; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Lot of anxiety) and TEARFULNESS (Very teary) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010a21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ANXIETY (Lot of anxiety) and TEARFULNESS (Very teary). At the time of the report, ANXIETY (Lot of anxiety) and TEARFULNESS (Very teary) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Urticaria
Clinical narrative: itchy; hives; redness; rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), URTICARIA (hives), ERYTHEMA (redness) and RASH (rash) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchy), URTICARIA (hives), ERYTHEMA (redness) and RASH (rash). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (ANTIHISTAMINE ALLERGY RELIEF) at an unspecified dose and frequency. At the time of the report, PRURITUS (itchy), URTICARIA (hives), ERYTHEMA (redness) and RASH (rash) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Treatment details included Tylenol, antihistamine.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Diarrhoea
Clinical narrative: severe diarrhea; burn sensation from insertion of needle; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burn sensation from insertion of needle) and DIARRHOEA (severe diarrhea) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis, Food allergy (Mushroom) and Drug allergy (Amoxicillin). Concomitant products included ADALIMUMAB (HUMIRA) for Immunosuppressant drug therapy, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HCTZ) and METOPROLOL for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced BURNING SENSATION (burn sensation from insertion of needle). On 22-Feb-2021, the patient experienced DIARRHOEA (severe diarrhea). On 12-Feb-2021, BURNING SENSATION (burn sensation from insertion of needle) had resolved. At the time of the report, DIARRHOEA (severe diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Eye disorder
Clinical narrative: Having an adverse reaction which deals with his eyes; This spontaneous case was reported by a consumer and describes the occurrence of EYE DISORDER (Having an adverse reaction which deals with his eyes) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 02-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EYE DISORDER (Having an adverse reaction which deals with his eyes). At the time of the report, EYE DISORDER (Having an adverse reaction which deals with his eyes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Lip dry, Rash
Clinical narrative: lips are so dry; Red; rash in her face, around their teeth, nose and forehead; This spontaneous case was reported by a consumer and describes the occurrence of LIP DRY (lips are so dry), ERYTHEMA (Red) and RASH (rash in her face, around their teeth, nose and forehead) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021L20A and 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced RASH (rash in her face, around their teeth, nose and forehead). On an unknown date, the patient experienced LIP DRY (lips are so dry) and ERYTHEMA (Red). At the time of the report, LIP DRY (lips are so dry), ERYTHEMA (Red) and RASH (rash in her face, around their teeth, nose and forehead) had not resolved.            Concomitant medication included unspecified high blood pressure medication. No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site erythema, Vaccination site induration, Vaccination site swelling
Clinical narrative: bump is firm; pain in shoulder; has a pretty big bump at the site of injection; bump is red; This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE INDURATION (bump is firm), ARTHRALGIA (pain in shoulder), VACCINATION SITE SWELLING (has a pretty big bump at the site of injection) and VACCINATION SITE ERYTHEMA (bump is red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE INDURATION (bump is firm), ARTHRALGIA (pain in shoulder), VACCINATION SITE SWELLING (has a pretty big bump at the site of injection) and VACCINATION SITE ERYTHEMA (bump is red). On 04-Mar-2021, ARTHRALGIA (pain in shoulder) had resolved. At the time of the report, VACCINATION SITE INDURATION (bump is firm), VACCINATION SITE SWELLING (has a pretty big bump at the site of injection) and VACCINATION SITE ERYTHEMA (bump is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea, Pain in extremity
Clinical narrative: nausea; sore arm; dizziness; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), DIZZINESS (dizziness), HEADACHE (headache) and NAUSEA (nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), DIZZINESS (dizziness) and HEADACHE (headache). On 04-Mar-2021, the patient experienced NAUSEA (nausea). On 04-Mar-2021, PAIN IN EXTREMITY (sore arm), DIZZINESS (dizziness), HEADACHE (headache) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD21-045026 (Linked Report).; Sender's Comments:  MOD21-045026: US-MODERNATX, INC.-MOD-2021-036207:Crosslinked case